New York, NY (PRWEB) September 06, 2017
The Lymphoma Research Foundation (LRF) – the nation’s largest non-profit organization devoted exclusively to funding innovative lymphoma research and serving the lymphoma community through a comprehensive series of education programs, outreach initiatives and patient services – today announced a new partnership with the Annals of Lymphoma (AOL), an open-access, international peer-reviewed electronic journal with worldwide distribution that publishes articles around key findings in basic and translational science, and clinical research relating to human lymphoma. This first-of-its-kind partnership will kick off during the month of September, Blood Cancer Awareness Month, in an effort to establish more direct lines of communication between the patient and research communities.
“For those who have dedicated their lives to the study of lymphoma or to advocating on behalf of patients, we understand that we must continually innovate to develop new therapies and treat patients - not just their disease,” said Bruce D. Cheson, MD, FACP, FAAS, FASCO, Editor-in-Chief of the Annals of Lymphoma and past-Chair of LRF’s Scientific Advisory Board from 2010-2012. “This commitment demands a collaborative approach to address the evolving needs of the lymphoma community, inspiring new partnerships such as this throughout our field.”
The Lymphoma Research Foundation will partner with both the Annals of Lymphoma and the Annals of Oncology throughout the month of September and beyond, in order to establish more direct lines of communication between lymphoma researchers and the patients they support. The partnership’s awareness efforts will culminate in Light it Red for Lymphoma on September 15th, World Lymphoma Awareness Day, an initiative spearheaded by LRF during which over 100 of the world’s most recognizable landmarks will “light red” in support of blood cancer research.
“Our patient-first focus is central to the Foundation’s mission to eradicate lymphoma and serve all those impacted by a lymphoma diagnosis,” said Meghan Gutierrez, LRF Chief Executive Officer. “To date, LRF has awarded nearly $60 million in lymphoma-specific research and our unique focus on young investigators has enabled countless early-career scientists to maintain their interest in the study of hematological malignancies, many of whom will most certainly secure headlines in the Annals of Lymphoma in the years to come.”
About the Lymphoma Research Foundation
The Lymphoma Research Foundation (LRF) is the nation’s largest non-profit organization devoted to funding innovative research and serving the lymphoma community through a comprehensive series of education programs, outreach initiatives and patient services. To date, LRF has awarded nearly $60 million in lymphoma-specific research.
For additional information on LRF’s research, education and services, visit lymphoma.org.
About the Annals of Lymphoma
The Annals of Lymphoma (Ann Lymphoma; AOL) is an open-access, international peer-reviewed electronic journal, and openly distributed worldwide. It publishes articles that describe advances in basic and translational science, and clinical findings relating to human lymphoma. Specific areas of interest include, but are not limited to: epidemiology, biology, genetics, immunology, diagnosis, treatment, and measures of assessment of response. The aim of the journal is to provide a forum for the dissemination of original research articles, as well as reviews and perspectives in these areas as they relate to human lymphoma. The journal features an international Editorial Board comprised of distinguished specialists who have dedicated their careers to the study of lymphoma in the laboratory and the clinic. They will bring their broad spectrum of experience to assist the journal in achieving its goals.